Feds Join Ranks of Employers with Generous Fertility Benefits
Starting this year, federal employees can choose plans that cover a broad menu of fertility services, including up to $25,000 annually for in vitro fertilization procedures. At the same time, politics around IVF and reproductive health have become a central issue in the current election-year debate.
If You’re Poor, Fertility Treatment Can Be Out of Reach
For low-income people who are on Medicaid or whose employer health plan is skimpy, help for infertility seems unattainable.
Si eres pobre, un tratamiento de fertilidad suele ser un sueño inaccesible
Pero las personas con ingresos más bajos, a menudo de minorías, tienen más probabilidades de estar cubiertas por Medicaid o por seguros limitados que no tienen esta cobertura.
Mammography AI Can Cost Patients Extra. Is It Worth It?
Artificial intelligence software to aid radiologists in detecting problems or diagnosing cancer has been moving rapidly into clinical use, where it shows great promise. But it’s a turnoff for some patients asked to pay out-of-pocket for technology that’s not quite ready for prime time.
Mamografías que usan inteligencia artificial cuestan dinero extra… pero, ¿vale la pena?
Este software puede identificar patrones y anomalías que los radiólogos humanos podrían pasar por alto. Pero no es el estándar de atención.
Grassroots College Networks Distribute Emergency Contraceptives on Campus
Peer-to-peer efforts can meet a clear need among students whose colleges may not make sexual health products accessible or affordable.
Compensation Is Key to Fixing Primary Care Shortage
Many proposals have been floated about how to address the nation’s primary care problem. They range from training slots to medical school debt forgiveness but often sidestep comprehensive payment reform.
Trump Misplaced Blame When He Said Drug Shortages Were Biden’s Fault
Former President Donald Trump, who’s running for another term in the White House, recently blamed drug shortages on his successor, President Joe Biden. Our findings don’t align with Trump’s claims; by some measures, drug shortages increased more on Trump’s watch than on Biden’s.
Resurge la hepatitis C, ¿podrá el plan de Biden eliminar este viejo flagelo en cinco años?
Se calcula que el 40% de los más de 2 millones de personas con hepatitis C en Estados Unidos ni siquiera saben que la tienen, pero el virus puede estar dañando silenciosamente su hígado, causando cicatrices, insuficiencia hepática o cáncer de hígado.
Hep C’s Number Comes Up: Can Biden’s 5-Year Plan Eliminate the Longtime Scourge?
Before covid-19, hepatitis C held the distinction of claiming more American lives each year than any other infectious disease — that’s despite the marketing of several relatively affordable, highly effective treatments.